Drug Profile
GS 1590
Latest Information Update: 27 Oct 2011
Price :
$50
*
At a glance
- Originator Cephalon; LEO Pharma
- Developer LEO Pharma
- Class Neuroprotectants; Vitamins
- Mechanism of Action Brain-derived neurotrophic factor expression stimulants; Nerve growth factor stimulants; Neuron stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurological disorders
Most Recent Events
- 23 Aug 2002 Discontinued - Preclinical for Neurological disorders in Denmark (unspecified route)
- 25 Jul 2001 This compound is still in active development
- 25 Aug 1999 Preclinical development for Neurological disorders in Denmark (Unknown route)